Avalon Globocare Corp AVCO:NASDAQ

Last Price$0.92Cboe Real-Time Last Sale as of 11:14AM ET 12/01/21
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.03(3.13%)
Bid (Size)$0.93 (100)
Ask (Size)$0.97 (100)
Day Low / High$0.92 - 1.02
Volume70.8 K

View Biotechnology IndustryPeer Comparison as of 12/01/2021


Avalon Globocare Corp ( NASDAQ )

Price: $0.92
Change: -0.03 (3.13%)
Volume: 70.8 K
11:14AM ET 12/01/2021

Capricor Therapeutics Inc ( NASDAQ )

Price: $3.25
Change: -0.12 (3.56%)
Volume: 116.0 K
1:55PM ET 12/01/2021

Astria Therapeutics Inc ( NASDAQ )

Price: $5.89
Change: -0.47 (7.39%)
Volume: 74.3 K
1:40PM ET 12/01/2021

Genocea Biosciences Inc ( NASDAQ )

Price: $1.32
Change: -0.03 (2.22%)
Volume: 40.2 K
1:04PM ET 12/01/2021

GlycoMimetics Inc ( NASDAQ )

Price: $1.67
Change: -0.02 (1.18%)
Volume: 166.1 K
1:49PM ET 12/01/2021

Read more news Recent News

Avalon GloboCare Files US, International Patent Applications for S-Layer Coated Emulsome Technology
10:32AM ET 10/14/2021 MT Newswires

Avalon GloboCare (AVCO) said Thursday it has filed US and international patent applications for the novel S-layer coated emulsome technology platform it...

Avalon GloboCare Acquisition Target SenlangBio Starts Trial of CAR-T Cell Therapy for Recurrent Glioblastoma
1:03PM ET 7/01/2021 MT Newswires

Avalon GloboCare (AVCO) said Thursday the Chinese biotech company it has agreed to acquire, SenlangBio, has started a first-in-humans clinical trial of its...

Avalon GloboCare to Acquire SenlangBio in All-Stock Deal
9:45AM ET 6/14/2021 MT Newswires

Avalon GloboCare (AVCO) on Monday said that it struck a deal to acquire Hebei Senlang Biotechnology, a cellular therapy company operating in northern...

Avalon GloboCare Expands Co-Development Project with MIT to Fight Cancer Spread
2:48PM ET 3/22/2021 MT Newswires

Avalon GloboCare Corp. (AVCO) said Monday it is expanding its co-development research project with the Massachusetts Institute of Technology to apply...

View all Commentary and Analysis

Atossa Therapeutics: Diversification Into COVID Makes Sense In A Variants World
2:27PM ET 9/22/2021 Seeking Alpha

Company Profile

Business DescriptionAvalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and provision of healthcare services. It operates through the following segments: Real Property Operating; Medical Related Consulting Services; and Development Services & Sales of Developed Products. It offers regenerative medicine, cell-based immunotherapy, exosome technology, and rehabilitation medicine through Avalon Cell and Avalon Rehab platforms. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ. View company web site for more details
Address4400 Route 9 South
Freehold, New Jersey 07728
Number of Employees10
Recent SEC Filing11/24/2021PRER14A
President, Chief Executive Officer & DirectorDavid K. Jin
Chief Operating Officer, Secretary & DirectorMeng Li
Chief Financial OfficerLuisa I. Ingargiola

Company Highlights

Price Open$1.02
Previous Close$0.95
52 Week Range$0.80 - 1.65
Market Capitalization$79.1 M
Shares Outstanding86.0 M
SectorHealth Technology
Next Earnings Announcement03/29/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.12
Beta vs. S&P 500N/A
Revenue$1.6 M
Net Profit Margin-652.18%
Return on Equity-284.75%